Compare ImmunityBio Inc. Common Stock (IBRX) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs D Wave Quantum Inc — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while D Wave Quantum Inc trades at $14.86 (market cap $5.78B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, D Wave Quantum Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and D Wave Quantum Inc for 32 Days on average.
| IBRX | QBTS | |
|---|---|---|
Market Cap | $10.33B | $5.78B |
Volume | 11,745,198 | 14,335,003 |
Sector | Health | Technology |
52-Week High | $11.55 | $44.78 |
52-Week Low | $1.98 | $12.98 |
Typical Hold Time | 0 Days | 32 Days |
Enterprise Value | $10.79B | $5.28B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QBTS (D-Wave Quantum Inc.) trades at $15.22, down 3.61% on the day, amid a bearish technical signal despite a 100% analyst buy rating with a consensus price target of $34.38. The company shows significant financial strain with a net income margin of -2,001.59% and negative cash flow from operations, though it maintains a high gross margin of 64.19%. Recent news highlights ongoing fraud investigations alongside technological advancements in quantum computing.
The stock presents high risk due to severe losses and cash burn, but offers speculative upside if the company can monetize its quantum technology. Investors face substantial volatility from operational challenges and legal scrutiny, requiring caution despite Wall Street optimism.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
